#Cardiovascular_Risk
Lilly's Mounjaro Receives FDA Approval for Cardiovascular Risk Reduction in Type 2 Diabetes Patients#USA#Indianapolis#Eli_Lilly#Mounjaro#Cardiovascular_Risk
Lilly's Mounjaro Receives FDA Approval for Cardiovascular Risk Reduction in Type 2 Diabetes Patients
Eli Lilly's Mounjaro gets FDA approval for lowering cardiovascular risks in adults with type 2 diabetes, enhancing its existing benefits for blood sugar control.
third-news.com
August 28, 2026 at 11:09 AM
Mass General Brigham Introduces Novel Genetic Test for Heart Disease Risk Assessment#USA#Boston#Cardiovascular_Risk#Mass_General#Genetic_Test
Mass General Brigham Introduces Novel Genetic Test for Heart Disease Risk Assessment
Mass General Brigham's new genetic test utilizes advanced genomic insights to predict risks for eight major cardiovascular conditions, enhancing personalized healthcare.
third-news.com
September 3, 2025 at 12:26 PM